FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202005642> ?p ?o ?g. }

• W3202005642 endingPage "13" @default.
• W3202005642 startingPage "13" @default.
• W3202005642 abstract "To report 1-year follow-up of a phase 1/2a clinical trial testing a composite subretinal implant having polarized human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) cells on an ultrathin parylene substrate in subjects with advanced non-neovascular age-related macular degeneration (NNAMD).The phase 1/2a clinical trial included 16 subjects in two cohorts. The main endpoint was safety assessed at 365 days using ophthalmic and systemic exams. Pseudophakic subjects with geographic atrophy (GA) and severe vision loss were eligible. Low-dose tacrolimus immunosuppression was utilized for 68 days in the peri-implantation period. The implant was delivered to the worst seeing eye with a custom subretinal insertion device in an outpatient setting. A data safety monitoring committee reviewed all results.The treated eyes of all subjects were legally blind with a baseline best-corrected visual acuity (BCVA) of ≤ 20/200. There were no unexpected serious adverse events. Four subjects in cohort 1 had serious ocular adverse events, including retinal hemorrhage, edema, focal retinal detachment, or RPE detachment, which was mitigated in cohort 2 using improved hemostasis during surgery. Although this study was not powered to assess efficacy, treated eyes from four subjects showed an increased BCVA of >5 letters (6-13 letters). A larger proportion of treated eyes experienced a >5-letter gain when compared with the untreated eye (27% vs. 7%; P = not significant) and a larger proportion of nonimplanted eyes demonstrated a >5-letter loss (47% vs. 33%; P = not significant).Outpatient delivery of the implant can be performed routinely. At 1 year, the implant is safe and well tolerated in subjects with advanced dry AMD.This work describes the first clinical trial, to our knowledge, of a novel implant for advanced dry AMD." @default.
• W3202005642 created "2021-10-11" @default.
• W3202005642 creator A5003920371 @default.
• W3202005642 creator A5008691406 @default.
• W3202005642 creator A5014073499 @default.
• W3202005642 creator A5015147725 @default.
• W3202005642 creator A5019183429 @default.
• W3202005642 creator A5020451747 @default.
• W3202005642 creator A5028255639 @default.
• W3202005642 creator A5029772677 @default.
• W3202005642 creator A5035760552 @default.
• W3202005642 creator A5039591590 @default.
• W3202005642 creator A5049346197 @default.
• W3202005642 creator A5051011191 @default.
• W3202005642 creator A5051846193 @default.
• W3202005642 creator A5052140640 @default.
• W3202005642 creator A5056027751 @default.
• W3202005642 creator A5057183556 @default.
• W3202005642 creator A5058337870 @default.
• W3202005642 creator A5061764059 @default.
• W3202005642 creator A5069200364 @default.
• W3202005642 creator A5076107728 @default.
• W3202005642 creator A5081668399 @default.
• W3202005642 creator A5083998794 @default.
• W3202005642 date "2021-10-06" @default.
• W3202005642 modified "2023-10-01" @default.
• W3202005642 title "One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration" @default.
• W3202005642 cites W1985312130 @default.
• W3202005642 cites W1994071473 @default.
• W3202005642 cites W2012271461 @default.
• W3202005642 cites W2022073599 @default.
• W3202005642 cites W2035318710 @default.
• W3202005642 cites W2048892017 @default.
• W3202005642 cites W2088419847 @default.
• W3202005642 cites W2123926492 @default.
• W3202005642 cites W2149884610 @default.
• W3202005642 cites W2342551546 @default.
• W3202005642 cites W2343804072 @default.
• W3202005642 cites W2418423387 @default.
• W3202005642 cites W2460914536 @default.
• W3202005642 cites W2598520882 @default.
• W3202005642 cites W2601350462 @default.
• W3202005642 cites W2784970892 @default.
• W3202005642 cites W2791013442 @default.
• W3202005642 cites W2795836363 @default.
• W3202005642 cites W2971597914 @default.
• W3202005642 cites W2979723684 @default.
• W3202005642 cites W3080431010 @default.
• W3202005642 cites W804972530 @default.
• W3202005642 doi "https://doi.org/10.1167/tvst.10.10.13" @default.
• W3202005642 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8496407" @default.
• W3202005642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34613357" @default.
• W3202005642 hasPublicationYear "2021" @default.
• W3202005642 type Work @default.
• W3202005642 sameAs 3202005642 @default.
• W3202005642 citedByCount "25" @default.
• W3202005642 countsByYear W32020056422022 @default.
• W3202005642 countsByYear W32020056422023 @default.
• W3202005642 crossrefType "journal-article" @default.
• W3202005642 hasAuthorship W3202005642A5003920371 @default.
• W3202005642 hasAuthorship W3202005642A5008691406 @default.
• W3202005642 hasAuthorship W3202005642A5014073499 @default.
• W3202005642 hasAuthorship W3202005642A5015147725 @default.
• W3202005642 hasAuthorship W3202005642A5019183429 @default.
• W3202005642 hasAuthorship W3202005642A5020451747 @default.
• W3202005642 hasAuthorship W3202005642A5028255639 @default.
• W3202005642 hasAuthorship W3202005642A5029772677 @default.
• W3202005642 hasAuthorship W3202005642A5035760552 @default.
• W3202005642 hasAuthorship W3202005642A5039591590 @default.
• W3202005642 hasAuthorship W3202005642A5049346197 @default.
• W3202005642 hasAuthorship W3202005642A5051011191 @default.
• W3202005642 hasAuthorship W3202005642A5051846193 @default.
• W3202005642 hasAuthorship W3202005642A5052140640 @default.
• W3202005642 hasAuthorship W3202005642A5056027751 @default.
• W3202005642 hasAuthorship W3202005642A5057183556 @default.
• W3202005642 hasAuthorship W3202005642A5058337870 @default.
• W3202005642 hasAuthorship W3202005642A5061764059 @default.
• W3202005642 hasAuthorship W3202005642A5069200364 @default.
• W3202005642 hasAuthorship W3202005642A5076107728 @default.
• W3202005642 hasAuthorship W3202005642A5081668399 @default.
• W3202005642 hasAuthorship W3202005642A5083998794 @default.
• W3202005642 hasBestOaLocation W32020056421 @default.
• W3202005642 hasConcept C118487528 @default.
• W3202005642 hasConcept C126322002 @default.
• W3202005642 hasConcept C141071460 @default.
• W3202005642 hasConcept C197934379 @default.
• W3202005642 hasConcept C2776403814 @default.
• W3202005642 hasConcept C2778024200 @default.
• W3202005642 hasConcept C2778257484 @default.
• W3202005642 hasConcept C2780827179 @default.
• W3202005642 hasConcept C2781411149 @default.
• W3202005642 hasConcept C535046627 @default.
• W3202005642 hasConcept C71924100 @default.
• W3202005642 hasConceptScore W3202005642C118487528 @default.
• W3202005642 hasConceptScore W3202005642C126322002 @default.
• W3202005642 hasConceptScore W3202005642C141071460 @default.
• W3202005642 hasConceptScore W3202005642C197934379 @default.
• W3202005642 hasConceptScore W3202005642C2776403814 @default.

• next